Sprouts Farmers Market (SFM) is a dominant player in the health-focused grocery niche. With $8.8 billion in revenue in 2025 and 7.3% comparable store sales growth, the company operates with solid margins and aggressive share buybacks. Currently, following a 64% technical correction from its 2025 highs, SFM trades at a forward P/E of 11x, presenting […]
Novo Nordisk (NVO) shares plummeted over 21% in 48 hours following REDEFINE 4 trial data, where CagriSema showed a 23% weight loss compared to Eli Lilly’s Zepbound at 25.5%. Despite the market’s knee-jerk reaction, fundamental analysis reveals a 2026 P/E of 11x, a massive discount compared to Lilly’s 30x. With a robust pipeline including oral
As of February 2026, my portfolio state of play centers on a strategic pivot toward long-term fixed income (41.3% in US Treasuries) and high-quality technology (MSFT). Diversified across defensive sectors (GIS) and luxury (RACE), the portfolio prioritizes “moat-heavy” firms with sustainable EPS growth. I am currently capitalizing on the software sector correction and the divergence
In February 2026, the US markets reached a critical sentiment exhaustion point, evidenced by a Total Put/Call Ratio exceeding 1.0 and a Fear & Greed Index bottoming at 40. By identifying a major sector rotation from Consumer Staples (XLP) into Big Tech (MSFT) and leveraging Heikin Ashi resistance levels, I executed a high-conviction short trade
In February 2026, investing in Amazon has become a core value play following a 25% drawdown from its all-time highs. With a forward P/E of 22x and an expected five-year EPS CAGR of 18.5%, the company is doubling down on massive AI expansion via AWS and logistics infrastructure. Despite a record $200 billion Capex guidance
On February 17, 2026, General Mills (GIS) stock dropped over 6% following a downward revision of its fiscal 2026 guidance at the CAGNY Conference. The company now forecasts organic net sales between -1% and 0% and a decline in adjusted EPS of 2% to 1%. Despite the volume pressure and consumer fatigue, the 5.44% dividend
